Birchview Capital »

Camp4 Therapeutics Corp shares owned by Birchview Capital

Quarter-by-quarter ownership of Camp4 Therapeutics Corp (CAMP) shares owned by Birchview Capital from 13F filings

Historical chart of Birchview Capital investment in Camp4 Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Camp4 Therapeutics Corp held by Birchview Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Camp4 Therapeutics Corp by Birchview Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $524k 120k 4.37

More positions owned by Birchview Capital

Kla Corporation Com New (KLAC)
Bristol Myers Squibb (BMY)
Lam Research Corporation Com New (LRCX)
Solid Biosciences Com New (SLDB)
Intellia Therapeutics (NTLA)
Biodesix
Stoke Therapeutics (STOK)
Encana Corporation (OVV)
Nektar Therapeutics (NKTR)
Corcept Therapeutics Incorporated (CORT)
Neurocrine Biosciences (NBIX)
Prothena Corp SHS (PRTA)
ACADIA Pharmaceuticals (ACAD)
Protagonist Therapeutics (PTGX)
Compass Therapeutics (CMPX)

View all positions for Birchview Capital

Top funds holding Camp4 Therapeutics Corp

Jupiter Topco
Henderson Group
5AM Venture Management
FMR
Vivo Capital
Balyasny Asset Management
AH Capital Management
Adage Capital Partners GP
Trails Edge Capital Partners
BlackRock
Vanguard Capital Management
Enavate Sciences GP
Stonepine Capital Management
HarbourVest Partners
Geode Capital Management

View all funds holding Camp4 Therapeutics Corp